Recombinant proteins are produced through genetic engineering, where the gene encoding the protein is inserted into a host organism, such as Escherichia coli (E. coli), to express the protein. This technique allows for large-scale production of proteins for research, therapeutic, and diagnostic purposes.
Expression Host: Typically, E. coli is used for expressing recombinant proteins due to its well-understood genetics and ease of manipulation.
Purification: Recombinant proteins are often purified using techniques like affinity chromatography, especially when tagged with sequences like His-tags.
Applications: These proteins are used in research to study protein function, in diagnostics to detect diseases, and in therapeutics as vaccines or drugs.
While specific data on HI_0850 is not available, research on other Haemophilus influenzae proteins highlights the importance of understanding bacterial pathogenesis. For example, proteins like Haemophilus influenzae protein E (PE) play crucial roles in adhesion and immune evasion . Additionally, tools like the pTBH plasmid toolkit have been developed to study H. influenzae infection dynamics .
Genetic Diversity: H. influenzae exhibits significant genetic diversity, making it challenging to develop universal diagnostic and therapeutic strategies .
Recombination: Frequent genetic recombination with other Haemophilus species complicates species identification and study .
Recombinant proteins can be used to develop vaccines, diagnostic tools, and therapeutic agents. For instance, recombinant porins from H. influenzae have been studied for their pore-forming properties .
| Protein | Source | Tag | Length | Form | Purity |
|---|---|---|---|---|---|
| HI_0870.1 | E. coli | His | Full Length (1-96) | Lyophilized powder | >90% |
| HI_0234 | E. coli | Variable | Full Length (1-48) | Liquid/Lyophilized | >85% |
Note: The table provides characteristics of similar recombinant proteins from Haemophilus influenzae for reference.
KEGG: hin:HI0850
STRING: 71421.HI0850